LRMR logo

Larimar Therapeutics (LRMR)

Profile

Full Name

Larimar Therapeutics, Inc.

Ticker Symbol

LRMR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 19, 2014

Indexes

Not included

Website

http://larimartx.com

Employees

65

Key Details

Price

$1.81(+1.69%)

Market cap

$115.89M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.32(-57.14% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.81
LRMR price is $1.81

30-Day Relative Volume

0.59
LRMR 30-day relative volume is 0.59

Price Performance

Price Most recent change

+1.69%
LRMR price was up +1.69% on Apr 11, 2025

Price YTD change

-53.23%
LRMR price is down -53.23% since January 1st

Price 1-year change

-73.99%
LRMR price is down -73.99% year-on-year

Price 3-year change

-48.73%
LRMR price is down -48.73% over the past 3 years

Price Range

Price All-time high

$55.36
LRMR price is currently -96.73% below its historical high of $55.36

Price 3-year low

$1.53
LRMR price is currently +18.30% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$115.89M
LRMR market capitalization is $115.89 million

Market cap 3-year change

+85.37%
LRMR market capitalization is up +85.37% over the past 3 years

Market cap All-time high

$792.39M
LRMR market capitalization is currently -85.37% below its historical high of $792.39 million

Market cap sector rank

50.94%
LRMR market capitalization is higher than 50.94% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.36%
LRMR shares outstanding is up +0.36% year-on-year

Shares Outstanding 3-Year Change

+261.53%
LRMR shares outstanding is up +261.53% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.34
LRMR beta is 1.34

200-day SMA

$5.83
LRMR price is currently -68.93% below its 200-day simple moving average

50-day SMA

$2.76
LRMR price is currently -34.33% below its 50-day simple moving average

RSI

34.45
LRMR 14-day relative strength index is 34.45

Volume

0.59
LRMR 30-day relative volume is 0.59

ATR

$0.19
LRMR average true range is $0.19

10-day Historical Volatility

117.37%
LRMR 10-day historical volatility is 117.37%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
LRMR annual revenue value is unknown

Revenue Analysts estimate

-
LRMR annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
LRMR annual revenue 1-year change is unknown

Revenue Sector rank

-
LRMR annual revenue is unknown

EPS

EPS

-$1.32
LRMR annual earnings per share is -$1.32

EPS Analysts estimate

-$1.81
LRMR annual earnings per share is currently -26.98% lower than the consensus analysts' forecast

EPS 1-year change

-57.14%
LRMR annual earnings per share is down -57.14% year-on-year

EPS Sector rank

49.22%
LRMR annual earnings per share is higher than 49.22% of companies in Healthcare sector

Profit

Gross profit

-
LRMR annual gross profit value is unknown

Gross margin

-
LRMR annual gross profit margin value is unknown

Operating profit

-$90.89M
LRMR annual operating income is -$90.89 million

Operating margin

-
LRMR annual operating profit margin value is unknown

Net income

-$80.60M
LRMR annual net profit is -$80.60 million

Net margin

-
LRMR annual net profit margin value is unknown

Expenses

Total expenses

$90.89M
LRMR annual total expenses is $90.89 million

Operating expenses

$90.89M
LRMR annual total operating expenses is $90.89 million

Cost of goods sold

-
LRMR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.61M
LRMR annual SGA is $17.61 million

Depreciation and amortization

$318.00K
LRMR annual depreciation & amortization is $318.00 thousand

Interest expense

-
LRMR annual interest expense value is unknown

Income tax

-
LRMR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$90.89M
LRMR annual earnings before interest & taxes is -$90.89 million

EBITDA

-$90.57M
LRMR annual EBITDA is -$90.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$200.22M
LRMR annual total assets is $200.22 million

Non current assets

$4.92M
LRMR annual long term assets is $4.92 million

Current assets

$195.30M
LRMR annual total current assets is $195.30 million

Cash and cash equivalents

$33.22M
LRMR annual cash & cash equivalents is $33.22 million

Accounts receivable

-
LRMR annual accounts receivable value is unknown

Inventory

-
LRMR annual inventory value is unknown

Liabilities

Total liabilities

$28.41M
LRMR annual total liabilities is $28.41 million

Long term liabilities

$4.06M
LRMR annual total long term liabilities is $4.06 million

Current liabilities

$24.36M
LRMR annual total current liabilities is $24.36 million

Accounts payable

$2.42M
LRMR annual accounts payable is $2.42 million

Debt

Total debt

$5.12M
LRMR annual total debt is $5.12 million

Total debt 1-year change

-7.74%
LRMR annual total debt is down -7.74% year-on-year

Long term debt

$4.06M
LRMR annual long term debt is $4.06 million

Short term debt

$1.06M
LRMR annual short term debt is $1.06 million

Equity & Capital

Shareholders equity

$171.81M
LRMR annual stockholders equity is $171.81 million

Book value

$171.81M
LRMR annual book value is $171.81 million

Retained earnings

-$269.16M
LRMR annual retained earnings is -$269.16 million

Working capital

$170.95M
LRMR annual working capital is $170.95 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$70.76M
LRMR annual cash flow from operations is -$70.76 million

Cash from operations 1-year change

-111.48%
LRMR annual cash flow from operations is down -111.48% year-on-year

Cash from investing

-$85.39M
LRMR annual cash flow from investing activities is -$85.39 million

Cash from investing 1-year change

-356.01%
LRMR annual cash flow from investing activities is down -356.01% year-on-year

Cash from financing

$161.88M
LRMR annual cash flow from financing activities is $161.88 million

Cash from financing 1-year change

+539510%
LRMR annual cash flow from financing activities is up +539510% year-on-year

CAPEX

CAPEX

-
LRMR annual capital expenditures value is unknown

CAPEX 1-year change

-
LRMR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$71.28M
LRMR annual free cash flow is -$71.28 million

Free cash flow 1-year change

-111.98%
LRMR annual free cash flow is down -111.98% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
LRMR annual gross profit margin value is unknown

Operating margin

-
LRMR annual operating profit margin value is unknown

Net margin

-
LRMR annual net profit margin value is unknown

ROA & ROE

ROA

-40.26%
LRMR annual return on assets is -40.26%

ROE

-46.91%
LRMR annual return on equity is -46.91%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LRMR price to earnings ratio value is unknown

PE ratio Sector rank

-
LRMR price to earnings ratio is unknown

PB Ratio

PB ratio

0.67
LRMR price to book ratio is 0.67

PB ratio Sector rank

36.1%
LRMR price to book ratio is higher than 36.1% of companies in Healthcare sector

PS Ratio

PS ratio

-
LRMR price to sales ratio value is unknown

PS ratio Sector rank

-
LRMR price to sales ratio is unknown

Enterprise value

Enterprise value

$87.79M
LRMR enterprise value is $87.79 million

Enterprise value Sector rank

48.72%
LRMR enterprise value is higher than 48.72% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.97
LRMR EV/EBITDA is -0.97

EV/EBITDA Sector rank

42.22%
LRMR EV/EBITDA is higher than 42.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.02
LRMR annual current ratio is 8.02

Quick ratio

-
LRMR annual quick ratio value is unknown

Leverage

Debt to equity

0.03
LRMR annual debt to equity ratio is 0.03

Interest coverage ratio

-
LRMR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
LRMR piotroski f-score value is unknown

Altman Z-Score

-
LRMR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 25, 25 HC Wainwright & Co.
Buy
Mar 25, 25 Guggenheim
Buy
Mar 25, 25 Baird
Outperform
Jan 29, 25 Truist Securities
Buy
Jan 24, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy
Dec 16, 24 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Oct 16, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

NKTR logo
Nektar Therapeutics (NKTR)
SCPH logo
scPharmaceuticals (SCPH)
KOD logo
Kodiak Sciences (KOD)
BTMD logo
biote (BTMD)
ZJYL logo
Jin Medical International (ZJYL)
OBIO logo
Orchestra BioMed Holdings (OBIO)
RAPT logo
RAPT Therapeutics (RAPT)
ALDX logo
Aldeyra Therapeutics (ALDX)
CGEN logo
Compugen (CGEN)
  • What is the ticker symbol for Larimar Therapeutics?
  • Does Larimar Therapeutics pay dividends?
  • What sector is Larimar Therapeutics in?
  • What industry is Larimar Therapeutics in?
  • What country is Larimar Therapeutics based in?
  • When did Larimar Therapeutics go public?
  • Is Larimar Therapeutics in the S&P 500?
  • Is Larimar Therapeutics in the NASDAQ 100?
  • Is Larimar Therapeutics in the Dow Jones?
  • When was Larimar Therapeutics's last earnings report?
  • When does Larimar Therapeutics report earnings?
  • Should I buy Larimar Therapeutics stock now?

What is the ticker symbol for Larimar Therapeutics?

The ticker symbol for Larimar Therapeutics is NASDAQ:LRMR

Does Larimar Therapeutics pay dividends?

No, Larimar Therapeutics does not pay dividends

What sector is Larimar Therapeutics in?

Larimar Therapeutics is in the Healthcare sector

What industry is Larimar Therapeutics in?

Larimar Therapeutics is in the Biotechnology industry

What country is Larimar Therapeutics based in?

Larimar Therapeutics is headquartered in United States

When did Larimar Therapeutics go public?

Larimar Therapeutics's initial public offering (IPO) was on June 19, 2014

Is Larimar Therapeutics in the S&P 500?

No, Larimar Therapeutics is not included in the S&P 500 index

Is Larimar Therapeutics in the NASDAQ 100?

No, Larimar Therapeutics is not included in the NASDAQ 100 index

Is Larimar Therapeutics in the Dow Jones?

No, Larimar Therapeutics is not included in the Dow Jones index

When was Larimar Therapeutics's last earnings report?

Larimar Therapeutics's most recent earnings report was on Mar 24, 2025

When does Larimar Therapeutics report earnings?

The next expected earnings date for Larimar Therapeutics is May 9, 2025

Should I buy Larimar Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page